Organization
Sadat City University
11 clinical trials
Clinical trial
Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease: A Randomized, Controlled Trial.Status: Active (not recruiting), Estimated PCD: 2024-10-31
Clinical trial
The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2024-12-30
Clinical trial
The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients. A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.Status: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients: Randomized, Double-Blind, Placebo-Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus: A Randomized, Controlled TrialStatus: Completed, Estimated PCD: 2022-06-01
Clinical trial
A Randomized Single-Blind Controlled Trial Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without ConstipationStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled TrialStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia: a Randomized, Double-blind, Placebo-controlled StudyStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients. Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled TrialStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative ColitisStatus: Recruiting, Estimated PCD: 2025-09-30